Antihypertensive efficacy of melothria maderaspatana leaf extract on sham-operated and uninephrectomized doca-salt hypertensive rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 21, Issue 1, 2010, Pages 27-42

  Veeramani, Chinnadurai ^a   Aristatle, Balakrishnan ^a   Pushpàvalli, Ganesan ^a   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

DOCA salt; hypertension; hypertrophy; MME; uninephrectomized rats

Indexed keywords

DRINKING WATER; MELOTHRIA MADERASPATANA EXTRACT; NIFEDIPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HYPERTENSION; KIDNEY; KIDNEY ARTERY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLANT LEAF; RAT; SHAM PROCEDURE; SURGICAL WOUND; SUTURE; SYSTOLIC BLOOD PRESSURE; WISTAR ALBINO GLAXO RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOMEGALY; CUCURBITACEAE; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; KIDNEY DISEASES; MALE; NEPHRECTOMY; NIFEDIPINE; ORGAN SIZE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR;

EID: 77953171014     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2010.21.1.27     Document Type: Article

References (30)

1. World Health Organization (WHO). International Society of Hypertension statement on management of hypertension. Vol. 21. WHO. 2003.
2. Zuckerman, BD, Yin, FC. Aortic impedance and compliance in hypertensive rats. Am J Physiol 1989;257:H553-62.
3. Cooke, T. Flora of Presidency of Bombay, Calcutta, India: BSI, 1967.
4. ndEd. New Delhi: Jayyed Press, International Book Distributors, 1975.
5. Nadkarni, KM. Indian Materia Medica. Bombay: Popular Prakashan Pvt Ltd., 1976.
6. Jayaweera, DMA. Medicinal plants used in Ceylon. Colombo: National Science Council, Sri Lanka Publication, 1982.
7. Collins Peto, R, MacMahon, S, Hebert, P, Fiebach, NH, Eberlien, KA. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990.
8. Zhou, Y, Luo, P, Chang, HH, Huang, H, Yang,T, Dong Z, Wang, CY, et al. Clofibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. Kidney Int 2008:74(8): 1040-8.
9. Sinha, BN, Sasmal, D, Basu, SP. Pharmacological studies on Melothria maderaspatana. Fitoterapia 1997;118:75-8.
10. Sinha, BN, Thanigavelan, J, Basu, SP. Studies on Melothria Maderaspatana (Linn). Cogn Ancient Sci Life 1996;15:238-40.
11. Bhattacharjee, AK, Das, AK. Phytochemical screening of Indian plants. Quart J Crude Drug Res 1969;9:1408-12.
12. Chopra, RN. Glossary of Indian Medicinal Plants. New Delhi: National Institutes of Science Communication and Information Resources (CSIR), 2002.
13. Vattem, DA, Ghaedian, R, Shetty, K. Enhancing health benefits of berries through phenolic antio. xidant enrichment: Focus on cranberry. Asia Pacific J Clin Nutr 2005;14:120-30.
14. ndedition. New York: Taylor and Francis, 2005.
15. Kwon, Yl, Vattem, DA, Shetty, K. Clonal herbs of lamiaceae species against diabetes and hypertension. Asia Pacific J Clin Nutr 2006; 15:107-18.
16. Actis-Goreta, L, Ottaviani, Jl, Keen, CL, Fraga, G. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 2003;555:597–600.
17. Ledesma, BH, Alvarez, MPJ, Pueyo, E. Assessment of spectrophotometric method for determination of angiotensin converting enzyme activity: Influence of inhibition type. J Agri Food Sci 2003;51:4175-9.
18. Crook, ED, Penumalee, S. Therapeutic controversies in hypertension management: Angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in diabetic nephropathy? ACE inhibitors. Ethnicity Dis 2004;14:1–4.
19. Johnston, Jl, Volhard, F. Renin-angiotensin system: A dual tissue and hormonal system for cardiovascular control. J Hypertens 1992; 10:13–26.
20. Suttie, JW. The biochemical basis of warfarin therapy. Exp Med Biol 1987;214:3–16.
21. Huang, HC, Lee, CR, Weng, YI, Lee, M, Lee, YT. Vasodilator effect of Scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur J Pharm 1992;218:123-8.
22. Paya, M, Halliwel, B, Hoult, JR. Interactions of a series of coumarins with reactive oxygen species: scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharm 1992;44:205-14.
23. Lichtenstein, AH, Deckelbaum, RJ. Stanol/Sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the nutrition committee of the council of nutrition, physical activity and metabolism of the American heart association. Circulation 2001;103:1177-9.
24. Sailaja, YR, Baskar, R, Srinivas Rao, CS. Membrane lipids and protein-bound carbohydrates status during the maturation of reticulocytes to erythrocytes in type 2 diabetics. Clin Chim Act 2004;341:185-92.
25. Raja, B, Kaviarasan, K, Arjunan, MM, Pugalendi, KV. Effect of Meiothria maderaspatana leaf-tea consumption on blood pressure, lipid profile, fibrinogen, bilurubin and albumin levels in patents with hypertension. J Altem Complement Med 2007;13:349-54.
26. Nunes, VW, Fortes, ZB, Nigro, D, Carvalho, MHC, Zorn, TMT, Scivoletto, R. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats. Gen Pharm 2000;34:11 7–25.
27. Fleckenstein, V. History of calcium antagonists. Cir Res 1983;52:3–16.
28. Kiowski, W, Erne, P, Bertel, O, Hulthen, UL, Ritz, R, Buhler, FR, Unchanged baroreflex sensitivity during acute and chronic antihypertensive therapy with nifedipine. J Hypertens 1983;1:365-7.
29. Pinto, YM, Paul, M, Ganten, D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovas Res 1998; 39:77–88.
30. Chan, V, Hoey, A, Brown, L. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol 2006; 148:902-8.